论文信息 - Combinatorial Screening of Peptides, Specific Ligands of Death Receptor DR5 - 字舞流文

Combinatorial Screening of Peptides, Specific Ligands of Death Receptor DR5

A. Belogurov | A. Stepanov | V. Ukrainskaya | A. G. Gabibov

[1] S. Fulda. Safety and tolerability of TRAIL receptor agonists in cancer treatment , 2015, European Journal of Clinical Pharmacology.

[2] E. Bremer. Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy , 2013, ISRN oncology.

[3] Y. Shukla,et al. Death receptors: targets for cancer therapy. , 2010, Experimental cell research.

[4] W. Quax,et al. Synthetic constrained peptide selectively binds and antagonizes death receptor 5 , 2010, The FEBS journal.

[5] M. Smyth,et al. Targeting death-inducing receptors in cancer therapy , 2007, Oncogene.

[6] Sachdev S Sidhu,et al. Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists. , 2006, Journal of molecular biology.

[7] Wafik S El-Deiry,et al. TRAIL and apoptosis induction by TNF-family death receptors , 2003, Oncogene.

[8] Morgan Huse,et al. The Death Domain Superfamily in Intracellular Signaling of Apoptosis and Inflammation , 2007 .